Seminars in Immunopathology

, Volume 31, Issue 4, pp 527–536

Central nervous system vasculitis

Review

Abstract

An account of the pathology, pathogenesis, clinical features, diagnosis and management of cerebral vasculitis is presented.

Keywords

CNS vasculitis Isolated CNS angiitis 

References

  1. 1.
    Younger DS, Hays AP, Brust JC, Rowland LP (1988) Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. Arch Neurol 45:514–518PubMedGoogle Scholar
  2. 2.
    Watts RA, Scott DG (1997) Classification and epidemiology of the vasculitides. Baillieres. Clin Rheumatol 11:191–217Google Scholar
  3. 3.
    Lie JT (1997) Classification and histopathologic spectrum of central nervous system vasculitis. Neurol Clin 15:805–819CrossRefPubMedGoogle Scholar
  4. 4.
    Schmidley JW (2000) Central nervous system angiitis. Butterworth-Heinemann, OxfordGoogle Scholar
  5. 5.
    Kolodny EH, Rebeiz JJ, Caviness VS Jr, Richardson EP Jr (1968) Granulomatous angiitis of the central nervous system. Arch Neurol 19:510–524PubMedGoogle Scholar
  6. 6.
    Jennette JC, Falk RJ, Milling DM (1994) Pathogenesis of vasculitis. Semin Neurol 14:291–299CrossRefPubMedGoogle Scholar
  7. 7.
    Salojin KV, Le TM, Nassovov EL, Blouch MT, Baranov AA, Saraux A, Guillevin L, Fiessinger JN, Piette JC, Youinou P (1996) Anti-endothelial cell antibodies in patients with various forms of vasculitis. Clin Exp Rheumatol 14:163–169PubMedGoogle Scholar
  8. 8.
    Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, Mackenzie JM, Xuereb JH, Love S (2005) A{beta}-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515CrossRefPubMedGoogle Scholar
  9. 9.
    Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, Piette JC (2001) Systemic vasculitis in patients with hepatitis C. J Rheumatol 28:109–118PubMedGoogle Scholar
  10. 10.
    Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2:661–670CrossRefPubMedGoogle Scholar
  11. 11.
    Mohan N, Kerr GS (2001) Diagnosis of vasculitis. Best Pract Res Clin Rheumatol 15:203–223CrossRefPubMedGoogle Scholar
  12. 12.
    Harper L, Williams JM, Savage CO (2004) The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis. Biochem Soc Trans 32:502–506CrossRefPubMedGoogle Scholar
  13. 13.
    Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955–963PubMedGoogle Scholar
  14. 14.
    Kallenberg CG (2008) Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30:29–36CrossRefPubMedGoogle Scholar
  15. 15.
    Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623–625CrossRefPubMedGoogle Scholar
  16. 16.
    Mathieson PW, Oliveira DB (1995) The role of cellular immunity in systemic vasculitis. Clin Exp Immunol 100:183–185PubMedGoogle Scholar
  17. 17.
    Lie JT (1997) Biopsy diagnosis of systemic vasculitis. Baillieres Clin Rheumatol 11:219–236CrossRefPubMedGoogle Scholar
  18. 18.
    Weyand CM, Ma-Krupa W, Goronzy JJ (2004) Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 3:46–53CrossRefPubMedGoogle Scholar
  19. 19.
    Scolding NJ, Jayne DR, Zajicek JP, Meyer PAR, Wraight EP, Lockwood CM (1997) The syndrome of cerebral vasculitis: recognition, diagnosis and management. Q J Med 90:61–73Google Scholar
  20. 20.
    Molloy ES, Singhal AB, Calabrese LH (2008) Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 67:1732–1735CrossRefPubMedGoogle Scholar
  21. 21.
    Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33:4–9CrossRefPubMedGoogle Scholar
  22. 22.
    Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMedGoogle Scholar
  23. 23.
    Sehgal M, Swanson JW, DeRemee RA, Colby TV (1995) Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 70:337–341CrossRefPubMedGoogle Scholar
  24. 24.
    Scolding NJ (1999) Neurological complications of rheumatological and connective tissue disorders. In: Scolding NJ (ed) Immunological and Inflammatory diseases of the central nervous system. Butterworth-Heinemann, Oxford, pp 147–180Google Scholar
  25. 25.
    Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A (2009) Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 39:124–145CrossRefPubMedGoogle Scholar
  26. 26.
    Zajicek JP, Scolding NJ, Foster O, Rovaris J, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis - diagnosis and management. Q J Med 92:103–117Google Scholar
  27. 27.
    Lie JT (1996) Vasculitis associated with infectious agents. Curr Opin Rheumatol 8:26–29CrossRefPubMedGoogle Scholar
  28. 28.
    Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS (1983) Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 14:543–553CrossRefPubMedGoogle Scholar
  29. 29.
    Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ (1970) Necrotizing angiitis associated with drug abuse. N Engl J Med 283:1003–1011PubMedGoogle Scholar
  30. 30.
    Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH (1996) Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology 46:1741–1743PubMedGoogle Scholar
  31. 31.
    Scolding NJ (1999) Cerebral vasculitis. In: Scolding NJ (ed) Immunological and Inflammatory diseases of the central nervous system. Butterworth-Heinemann, Oxford, pp 210–258Google Scholar
  32. 32.
    Calabrese LH, Mallek JA (1988) Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine 67:20–39CrossRefPubMedGoogle Scholar
  33. 33.
    Hankey G (1991) Isolated angiitis/angiopathy of the CNS. Prospective diagnostic and therapeutic experience. Cerebrovasc Dis 1:2–15CrossRefGoogle Scholar
  34. 34.
    Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WTC (1994) Diagnosing intracranial vasculitis: the roles of MR and angiography. Am J Neuroradiol 15:317–330PubMedGoogle Scholar
  35. 35.
    Cloft HJ, Phillips CD, Dix JE, McNulty BC, Zagardo MT, Kallmes DF (1999) Correlation of angiography and MR imaging in cerebral vasculitis. Acta Radiol 40:83–87PubMedGoogle Scholar
  36. 36.
    Koennecke HC (2006) Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 66:165–171CrossRefPubMedGoogle Scholar
  37. 37.
    Scolding N (2007) Can diffusion-weighted imaging improve the diagnosis of CNS vasculitis? Nat Clin Pract Neurol 3:608–609CrossRefPubMedGoogle Scholar
  38. 38.
    Akin E, Coen A, Momeni M (2009) PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Clin Rheumatol 28:737–738CrossRefPubMedGoogle Scholar
  39. 39.
    Atalay MK, Bluemke DA (2001) Magnetic resonance imaging of large vessel vasculitis. Curr Opin Rheumatol 13:41–47CrossRefPubMedGoogle Scholar
  40. 40.
    Alrawi A, Trobe J, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53:858–860PubMedGoogle Scholar
  41. 41.
    Hellmann DB, Roubenoff R, Healy RA, Wang H (1992) Central nervous system angiography: safety and predictors of a positive result in 125 consecutive patients evaluated for possible vasculitis. J Rheumatol 19:568–572PubMedGoogle Scholar
  42. 42.
    Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N (2002) The recognition, diagnosis and management of cerebral vasculitis: a European survey. Eur J Neurol 9:343–347CrossRefPubMedGoogle Scholar
  43. 43.
    Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, De GK, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44CrossRefPubMedGoogle Scholar
  44. 44.
    Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis [see comments]. Ann Intern Med 124:477–484PubMedGoogle Scholar
  45. 45.
    Jayne DR, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433–439CrossRefPubMedGoogle Scholar
  46. 46.
    Gaskin G, Pusey CD (2001) Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Ther Apher 5:176–181CrossRefPubMedGoogle Scholar
  47. 47.
    Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D (2004) Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15:717–721CrossRefPubMedGoogle Scholar
  48. 48.
    Unger L, Kayser M, Nusslein HG (2003) Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 62:587–588CrossRefPubMedGoogle Scholar
  49. 49.
    Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DBG, Lockwood CM, Waldman H (1990) Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 323:250–254PubMedCrossRefGoogle Scholar
  50. 50.
    Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM (2004) Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 31:1955–1958PubMedGoogle Scholar
  51. 51.
    Sneller MC (2005) Rituximab and Wegener’s granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 52:1–5CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Institute of Clinical NeurosciencesFrenchay HospitalBristolUK

Personalised recommendations